Investigation of approaches for internal target volume definition using 4-dimensional computed tomography in stereotactic body radiotherapy of lung cancer


Koksal C. , Donmez K. , Okutan M., Karaman S., Dagoglu S., Bilge H.

MEDICAL DOSIMETRY, vol.46, no.2, pp.136-142, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.1016/j.meddos.2020.10.004
  • Title of Journal : MEDICAL DOSIMETRY
  • Page Numbers: pp.136-142
  • Keywords: Lung cancer, 4DCT, MIP, AIP, SBRT, ITV, RADIATION-THERAPY, TUMOR LOCATION, CT IMAGES, MOTION, SCANS, MIP

Abstract

The present study was undertaken to investigate the suitability of alternative internal target volume (ITV) delineation strategies based on maximum intensity projection (MIP), average intensity projection (AIP), 2 extreme phases and 4 phases images relative to the ITV10phase in stereotactic body radiation therapy (SBRT) for lung cancer. The 4-dimensional computed tomography (4DCT) data of 15 lung cancer patients treated with SBRT in our clinic were used. Five different ITVs were generated as follows: merging GTVs from 10 phases (ITV10Phase); merging GTVs from 2 extreme phases (0%, 50%) (ITV2Phase); merging GTVs from 4 phases (0%, 20%, 50%, and 70%) (ITV4Phase); delineating GTV on MIP (ITVMIP), and delineating GTV on AIP (ITVAIP). PTV10Phase, PTV2Phase, PTV4Phase, PTVMIP, and PTVAIP were generated by adding a 5-mm margin around the related ITV. Volumetric analyses were performed for 4 ITVs and PTVs relative to ITV10phase and PTV10phase. SBRT plans made for all PTVs were evaluated for dosimetric effect of alternative ITV delineation strategies. The mean percentage overlap volume (POV) for PTV2phase, PTV4phase, PTVMIP, and PTVAIP relative to PTV10phase were 84.2 +/- 5.4%, 92.0 +/- 2.9%, 82.2 +/- 5.7%, and 73.8 +/- 9.3%, for lower-lobe tumors, respectively. The mean POV for PTV2phase, PTV4phase, PTVMIP, and PTVAIP relative to PTV10phase were 93.2 +/- 2.5%, 95.9 +/- 1.0%, 87.5 +/- 6.7%, and 83.3 +/- 6.8% for upper-lobe, respectively. For lower-lobe tumors the mean differences in V20 and MLD for plans based on PTV2phase and PTV4phase were <0.5% and <10 cGy, compared with a plan based on PTV10phase. The use of PTV based on 4 respiratory phases and a 5-mm margin is a safe approach to reduce the workload of target delineation for tumors located in both lower and upper lobes. (C) 2020 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.